Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-021385

Options or other derivatives

  • Sr. VP, Business Dev. acquired 83,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Luu Brendan Sr. VP, Business Dev. 2023-11-22 Grant or award · Stock Option (right to buy) +83,000 83,000 D: show line 1 in the form
Loading xslF345X05/form4.xml…